Citation
Karp P.D. Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Designin Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development, Blackwell Science Ltd, 1997.
Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Design
Read more from SRI
-
CTI expands clinical research network through acquisition of SRI Clinical Trial Unit; organizations launch strategic research partnership
Government and commercial clients will benefit from expanded capabilities and operations.
-
Rutgers students take an insider tour of SRI’s Princeton campus
Undergraduate researchers got hands-on demos of healthcare task guidance and night-vision imaging tech.
-
SRI-backed Valence AI raises $5M to integrate emotional intelligence into the trust stack
Emotional inference is becoming a new layer in digital identity and fraud-prevention systems.